Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hodgkin Disease 2Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

fludarabine phosphate 55Cyclophosphamide 49Peripheral Blood Stem Cell Transplantation 47Mycophenolic Acid 40Tacrolimus 38Whole-Body Irradiation 32Busulfan 27Cyclosporine 25Antilymphocyte Serum 25Methotrexate 21Filgrastim 21fludarabine 19Melphalan 19Radiotherapy 14Methylprednisolone 13Sirolimus 11Flow Cytometry 10Etoposide 10Alemtuzumab 10Cord Blood Stem Cell Transplantation 9Rituximab 8Psychiatric Rehabilitation 8Granulocyte Colony-Stimulating Factor 8Therapeutics 7Polymerase Chain Reaction 7thymoglobulin 6sargramostim 5Prednisone 5Ondansetron 4Immunologic Techniques 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × Leuprolide × Plasma cell × Clear all
NCT01343368 2017-12-05

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
19 enrolled 19 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡